Citius Pharmaceuticals Stock Forecast - Simple Regression
| CTXR Stock | USD 0.89 0.01 1.11% |
The Simple Regression forecasted value of Citius Pharmaceuticals on the next trading day is expected to be 0.82 with a mean absolute deviation of 0.12 and the sum of the absolute errors of 7.54. Citius Stock Forecast is based on your current time horizon. Although Citius Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Citius Pharmaceuticals' systematic risk associated with finding meaningful patterns of Citius Pharmaceuticals fundamentals over time.
As of today the relative strength index (rsi) of Citius Pharmaceuticals' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.30) | EPS Estimate Current Year 1.9 | EPS Estimate Next Year 3.1 | Wall Street Target Price 6 | EPS Estimate Current Quarter (0.24) |
Using Citius Pharmaceuticals hype-based prediction, you can estimate the value of Citius Pharmaceuticals from the perspective of Citius Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Citius Pharmaceuticals using Citius Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Citius using crowd psychology based on the activity and movement of Citius Pharmaceuticals' stock price.
Citius Pharmaceuticals Implied Volatility | 2.54 |
Citius Pharmaceuticals' implied volatility exposes the market's sentiment of Citius Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Citius Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Citius Pharmaceuticals stock will not fluctuate a lot when Citius Pharmaceuticals' options are near their expiration.
The Simple Regression forecasted value of Citius Pharmaceuticals on the next trading day is expected to be 0.82 with a mean absolute deviation of 0.12 and the sum of the absolute errors of 7.54. Citius Pharmaceuticals after-hype prediction price | USD 0.84 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Citius Pharmaceuticals to cross-verify your projections. Open Interest Against 2026-02-20 Citius Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Citius Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Citius Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Citius Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Citius Pharmaceuticals' open interest, investors have to compare it to Citius Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Citius Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Citius. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Citius Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Citius price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Citius using various technical indicators. When you analyze Citius charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Citius Pharmaceuticals Simple Regression Price Forecast For the 11th of January 2026
Given 90 days horizon, the Simple Regression forecasted value of Citius Pharmaceuticals on the next trading day is expected to be 0.82 with a mean absolute deviation of 0.12, mean absolute percentage error of 0.02, and the sum of the absolute errors of 7.54.Please note that although there have been many attempts to predict Citius Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Citius Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Citius Pharmaceuticals Stock Forecast Pattern
| Backtest Citius Pharmaceuticals | Citius Pharmaceuticals Price Prediction | Buy or Sell Advice |
Citius Pharmaceuticals Forecasted Value
In the context of forecasting Citius Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Citius Pharmaceuticals' downside and upside margins for the forecasting period are 0.01 and 8.51, respectively. We have considered Citius Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Citius Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Citius Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.157 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.1216 |
| MAPE | Mean absolute percentage error | 0.1036 |
| SAE | Sum of the absolute errors | 7.5377 |
Predictive Modules for Citius Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Citius Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Citius Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Citius Pharmaceuticals
For every potential investor in Citius, whether a beginner or expert, Citius Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Citius Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Citius. Basic forecasting techniques help filter out the noise by identifying Citius Pharmaceuticals' price trends.Citius Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Citius Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Citius Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Citius Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Citius Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Citius Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Citius Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Citius Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Citius Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Citius Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Citius Pharmaceuticals stock market strength indicators, traders can identify Citius Pharmaceuticals entry and exit signals to maximize returns.
| Accumulation Distribution | 21948.97 | |||
| Daily Balance Of Power | (0.14) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 0.87 | |||
| Day Typical Price | 0.87 | |||
| Price Action Indicator | 0.02 | |||
| Period Momentum Indicator | (0.01) |
Citius Pharmaceuticals Risk Indicators
The analysis of Citius Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Citius Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting citius stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.64 | |||
| Standard Deviation | 7.57 | |||
| Variance | 57.24 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Citius Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Citius Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Citius Stock
| 0.77 | AZN | AstraZeneca PLC ADR | PairCorr |
| 0.73 | MRK | Merck Company Aggressive Push | PairCorr |
| 0.72 | VLKAF | Volkswagen AG | PairCorr |
| 0.7 | VWAGY | Volkswagen AG 110 | PairCorr |
| 0.67 | JNJ | Johnson Johnson | PairCorr |
The ability to find closely correlated positions to Citius Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Citius Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Citius Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Citius Pharmaceuticals to buy it.
The correlation of Citius Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Citius Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Citius Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Citius Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Citius Stock Analysis
When running Citius Pharmaceuticals' price analysis, check to measure Citius Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Citius Pharmaceuticals is operating at the current time. Most of Citius Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Citius Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Citius Pharmaceuticals' price. Additionally, you may evaluate how the addition of Citius Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.